Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Tumor-Derived Exosomes as Diagnostic and Prognostic Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

NCT01344109 is registered in ClinicalTrials.gov with Leo W. Jenkins Cancer Center as lead sponsor.

NCT NCT01344109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01344109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Tumor-Derived Exosomes as Diagnostic and Prognostic Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Lead sponsor
Leo W. Jenkins Cancer Center
Phase
Observational
Overall status
Withdrawn
Start date
February 28, 2011
Completion date
December 31, 2014
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms